RETATRUTIDE: ONE COMPARATIVE REVIEW

The emerging class of GLP-1 receptor and GIP dual medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, offer promising progress in the control. Despite all three work by influencing blood levels , they distinguish in their unique mechanisms of performance. Semagl